3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
4
Sarcoma
1
NET
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Neuroendocrine Tumors
111
Pheochromocytoma
34
Carcinoma, Neuroendocrine
31
Pituitary Neoplasms
27
Paraganglioma
27
Thyroid Cancer, Papillary
26
Adrenocortical Carcinoma
21
Neoplasms
19
Gastro-enteropancreatic neuroendocrine tumor
19
Thyroid Neoplasms
17
Adrenal Gland Neoplasms
16
Stomach Neoplasms
14
Pancreatic Neoplasms
14
Multiple Endocrine Neoplasia Type 1
14
Carcinoid Tumor
13
Sarcoma
12
Prostatic Neoplasms
12
Lung Neoplasms
12
Thyroid Carcinoma, Anaplastic
11
Colorectal Neoplasms
11
Breast Neoplasms
11
Adenoma, Islet Cell
11
Neuroblastoma
10
Neoplasm Metastasis
10
Carcinoma, Hepatocellular
10
Brain Neoplasms
10
Small Cell Lung Carcinoma
9
Ovarian Neoplasms
9
Meningioma
9
Esophageal Neoplasms
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Seminoma
×
Endocrine
×
Clear all
NCT05500391
2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2
Recruiting
88 enrolled